SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: GregorioAllegri who wrote (4075)12/23/2015 3:15:34 PM
From: mulanoon2007  Respond to of 4474
 
I don't have access to the full Nature report but it looks like the 3 pts with CMR are from a study that was first reported at 2012 ASH; 27 pts enrolled, 24 evaluable, 7 drop-outs, with 17 treated for at least 12 months. Perhaps the Nature report shows other responses that did not reach CMR. Interesting results, thanks.

ash.confex.com